• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在急性 Vogt-Koyanagi-Harada 病中,全身皮质类固醇治疗可使视网膜下液消退。

Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.

机构信息

Department of Ophthalmology, Doheny Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Br J Ophthalmol. 2012 Nov;96(11):1410-4. doi: 10.1136/bjophthalmol-2012-301857. Epub 2012 Aug 31.

DOI:10.1136/bjophthalmol-2012-301857
PMID:22942161
Abstract

BACKGROUND

To evaluate the correlation of subretinal fluid height with visual acuity (VA) in patients with acute Vogt-Koyanagi-Harada disease (VKH).

METHODS

Clinical information, fundus photographs and spectral domain optical coherence tomography scans from sequential visits of patients with acute VKH treated with oral corticosteroids were analysed. Subretinal fluid (SRF) height and retinal thickness were measured at the fovea. The association between VA and SRF height was evaluated by Spearman correlation analysis.

RESULTS

A total of 12 eyes from 6 consecutive patients were included. SRF height measured 824±508 µm (range 45-1900 µm) at presentation. SRF height correlated with simultaneously measured VA. Initial SRF height did not correlate with resolution time and final VA. Resolution of SRF was attained in 36±24 days (range 10-80 days). The presence of choroidal folds (eight eyes) and multifocal retinal detachment (eight eyes) at presentation correlated with lower initial VA but not with the interval to SRF resolution or with VA at 3-month follow-up.

CONCLUSIONS

Serous retinal detachment resolved in 36±24 days in patients with acute VKH treated with oral corticosteroids. SRF height correlates with VA measured at the same time. The initial SRF, no matter how elevated, does not correlate with VA at 3 months after presentation.

摘要

背景

评估急性 Vogt-小柳-原田病(VKH)患者的视网膜下液高度与视力(VA)的相关性。

方法

分析了接受口服皮质类固醇治疗的急性 VKH 患者的连续就诊的临床信息、眼底照片和频域光相干断层扫描。在黄斑处测量视网膜下液(SRF)高度和视网膜厚度。通过 Spearman 相关分析评估 VA 与 SRF 高度之间的关系。

结果

共纳入 6 例连续患者的 12 只眼。在就诊时,SRF 高度为 824±508 µm(范围 45-1900 µm)。SRF 高度与同时测量的 VA 相关。初始 SRF 高度与恢复时间和最终 VA 无关。SRF 在 36±24 天(范围 10-80 天)内得到解决。就诊时存在脉络膜皱褶(8 只眼)和多灶性视网膜脱离(8 只眼)与初始 VA 较低相关,但与 SRF 恢复间隔或 3 个月随访时的 VA 无关。

结论

接受口服皮质类固醇治疗的急性 VKH 患者的浆液性视网膜脱离在 36±24 天内得到解决。SRF 高度与同时测量的 VA 相关。初始 SRF 高度无论多高,与就诊后 3 个月的 VA 无关。

相似文献

1
Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.在急性 Vogt-Koyanagi-Harada 病中,全身皮质类固醇治疗可使视网膜下液消退。
Br J Ophthalmol. 2012 Nov;96(11):1410-4. doi: 10.1136/bjophthalmol-2012-301857. Epub 2012 Aug 31.
2
Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.谱域光相干断层扫描和自发荧光在一例急性后多发性盘状色素上皮病变模仿 Vogt-Koyanagi-Harada 病的病例报告及文献复习。
Ocul Immunol Inflamm. 2011 Feb;19(1):42-7. doi: 10.3109/09273948.2010.521610. Epub 2010 Oct 31.
3
Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病视网膜下纤维化的纵向观察
BMC Ophthalmol. 2018 Jan 15;18(1):6. doi: 10.1186/s12886-018-0670-0.
4
Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.增强型谱域光学相干断层扫描下的急性Vogt-小柳-原田病
Ophthalmology. 2009 Sep;116(9):1799-807. doi: 10.1016/j.ophtha.2009.04.002. Epub 2009 Jul 30.
5
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.急性Vogt-小柳-原田病中伴有多叶状染料积聚的浆液性视网膜脱离的断层扫描特征。
Am J Ophthalmol. 2007 Aug;144(2):260-5. doi: 10.1016/j.ajo.2007.04.007. Epub 2007 May 29.
6
Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.急性Vogt-小柳-原田综合征中的视网膜囊样间隙
Am J Ophthalmol. 2005 Apr;139(4):670-7. doi: 10.1016/j.ajo.2004.11.053.
7
Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病急性和慢性期的光学相干断层扫描
Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):225-7. doi: 10.1080/09273940490912416.
8
The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.全身用皮质类固醇给药途径对急性Vogt-小柳-原田病脉络膜改变的影响
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1203-1211. doi: 10.1007/s00417-017-3654-5. Epub 2017 Apr 5.
9
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.评估急性Vogt-小柳-原田病中糖皮质激素给药途径对预后的影响。
Am J Ophthalmol. 2006 Jul;142(1):119-24. doi: 10.1016/j.ajo.2006.02.049.
10
Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study.急性中心性浆液性脉络膜视网膜病变、Vogt-小柳原田病和脉络膜血管瘤眼中的视网膜下液光密度比是否不同:一项横断面研究。
Photodiagnosis Photodyn Ther. 2023 Jun;42:103634. doi: 10.1016/j.pdpdt.2023.103634. Epub 2023 May 25.

引用本文的文献

1
Factors determining timing of first recurrence after three loading aflibercept injections in newly diagnosed neovascular age-related macular degeneration.新诊断的新生血管性年龄相关性黄斑变性患者在三次注射阿柏西普负荷剂量后首次复发时间的决定因素。
Jpn J Ophthalmol. 2025 Jun 12. doi: 10.1007/s10384-025-01225-z.
2
Vogt-Koyanagi-Harada Disease: A Narrative Review.伏格特-小柳-原田病:一篇叙述性综述
Cureus. 2024 Apr 23;16(4):e58867. doi: 10.7759/cureus.58867. eCollection 2024 Apr.
3
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration.
外层核层恢复可预测新生血管性年龄相关性黄斑变性 1 型脉络膜新生血管的视力预后。
Sci Rep. 2023 Mar 28;13(1):5045. doi: 10.1038/s41598-023-32184-5.
4
Bacillary Layer Detachment in Acute Vogt-Koyanagi-Harada Disease.急性 Vogt-小柳-原田病中的杆菌层脱离。
Turk J Ophthalmol. 2022 Dec 28;52(6):400-404. doi: 10.4274/tjo.galenos.2021.86821.
5
Different MicroRNA profiles in Peripheral Blood mononuclear cells from patients with initial-onset and recurrent vogt-Koyanagi-Harada Disease.初发和复发型Vogt-小柳-原田病患者外周血单个核细胞中的不同微小RNA谱
Mol Biol Rep. 2022 Dec;49(12):11421-11431. doi: 10.1007/s11033-022-07753-y. Epub 2022 Aug 21.
6
Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients.在初治的Vogt-小柳原田病患者中,阿达木单抗联合免疫抑制剂的无全身糖皮质激素治疗与传统治疗的比较
Ann Transl Med. 2022 Jun;10(12):699. doi: 10.21037/atm-22-2668.
7
[Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].[自体荧光联合光谱域光学相干断层扫描用于急性Vogt-小柳-原田病的诊断及随访]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):135-140. doi: 10.12122/j.issn.1673-4254.2021.01.20.
8
Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.局部用双氟泼尼酯治疗与小柳原田病相关的浆液性视网膜脱离和全葡萄膜炎。
Digit J Ophthalmol. 2016 Jun 28;22(2):54-7. doi: 10.5693/djo.02.2015.05.004. eCollection 2016.
9
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.伏格特-小柳-原田病:一种罕见的针对黑素细胞抗原的自身免疫性疾病的综述
Orphanet J Rare Dis. 2016 Mar 24;11:29. doi: 10.1186/s13023-016-0412-4.
10
[Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].[Vogt-小柳-原田综合征免疫抑制治疗的长期病程]
Ophthalmologe. 2015 Oct;112(10):857-60. doi: 10.1007/s00347-015-3238-x.